Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane

Clinical Rheumatology

Volumn 17, Issue 2, 1998, Pages 115-120

  Ribatti, D ^a,b   Cantatore, F P ^a   Vacca, A ^a   D'Amore, M ^a   Ria, R ^a   Roncali, L ^a   Pipitone, V ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Angiogenesis; Chorioallantoic membrane; Systemic sclerosis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL STRUCTURE; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

ADULT; ALLANTOIS; ANIMALS; CHICK EMBRYO; CHORION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SCLERODERMA, SYSTEMIC;

EID: 0031747466     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01452256     Document Type: Article

References (44)

1. Maricq HR. Widetield capillary microscopy. Technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 1981;24:1159-64.
2. Norton WL, Nardo JM. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med 1970;73:317-324.
3. 3H-thymidine labeling of dermal endothelial cells in scleroderma. J Invest Dermatol 1977;69:379-82.
4. Majewski S, Hunzelmann N, Johnson JP, Jung C, Mauch C. Ziegler-Heitbrock HWL. Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol 1991;97:667-71.
5. Sollberg S, Peltonen J, Vitto J, Jimenez SA. Elevated expression of beta1 and beta2 integrins. intercellular adhesion molecule-1. and endothelial leucocyte adhesion molecule-1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum. 1992;35:290-8.
6. Carvalho B, Savage COS, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest. 1996;97:111-9.
7. Moses MA, Klagsbrun M, Shing Y. The role of growth factors in vascular cell development and differentiation. Int Rev Cytol. 1995;161:1-48.
8. Sankar S, Mahooti-Brooks N, Bersen L, McCarthy TL, Centreila M, Madri JA. Modulation of transforming growth factorβ receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest. 1996;97:1436-46.
9. Folkman J, Brem H. Angiogenesis and inflammation. In: Gallin JL, Goldstein M, Snyderman R, editors. Inflammation: basic principles and clinical applications. New York: Raven Press, 1992:821-39.
10. Wolf JE Jr. Angiogenesis in normal and psoriatic skin. Lab Invest 1989;61:139.
11. Malhotra R, Stenn KS, Fernandez LA, Braverman IM. Angiogenic properties of normal and psoriatic skin associated with epidermis, not demnis. Lab Invest 1989;61:162-5.
12. Beranek JT. Angiogenesis in psoriasis. Lab Invest 1990;62:131.
13. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Bersc B, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissues. J Exp Med 1994;180:341-6.
14. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56.
15. Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE, Rosenbaum JT. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995;73:339-16.
16. Adamis AP, Miller JW, Bernai MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;.118:445-50.
17. Frank RN. Vascular endothelial growth factor. Its role in retinal vascular proliferation. New Engl J Med 1994;.331:1519-20.
18. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB. Schwartz SM. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994;.145:883-94.
19. Sunderkotter C, Steinbrink K, Goeheler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J Leukoc Biol 1994;.55:410-22.
20. Adams DH, Shaw S. Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 1994;.343:831-6.
21. Ribatti D, Vacca A, Roncali L, Dammacco F. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int J Dev Biol 1996;40:1189-97.
22. Subcommitee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
23. Elias H, Hyde DM. Stereological measurements of isotropic structures. In: Elias H, Hyde DM, editors. A guide to practical stereology. Karger: Basel,1983:25-44.
24. Ribatti D, Urbinati C, Nico B, Rusnati M, Roncali L, Presta M. Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev Biol 1995;170:39-49.
25. Wilting J, Christ B, Bokeloh M. A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers. PBS, angiogenin and bFGF. Anat Embryol 1991;183:259-71.
26. Olivo M, Bhardwaj R, Schulze-Osthof K, Sorg C, Jurgen-Jacob H, Flamme I. A comparative study on the effects of tumor necrosis factor alpha (TNFα. human angiogenin factor (h-AF) and basic fibroblast growth factor (bFGF) on the chorioallantoic membrane of the chick embryo. Anat Rec 1992;234:105-15.
27. Wilting J, Christ B, Weich HA. The effects of growth factors on the day 13 chorioallantoic membrane (CAM): a study of VEGF165 and PDGF-BB. Anat Embryol 1992;186:251-7.
28. Roberts AB, Sporn MB. Regulation of endothelial cell growth, architecture and matrix synthesis by TGFβ. Am J Resp Dis 1989;140:1126-8.
29. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M. T lymphocytes synthesize and export heparin-binding epidermal growth-factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ cells. Proc Natl Acad Sci USA 1994;91:2890-4.
30. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Nikdnejad K, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995;55:4140-5.
31. Ribatti D. Loria MP, Tursi A. Lymphocyte-induced angiogenesis: a morphometric study in the chick embryo chorioallantoic membrane. Acta Anat 1991;142:334-8.
32. Kon K, Fujwara T. Transformation of fibroblasts into endothelial cells during angiogenesis. Cell Tissue Res 1994;278:625-8.
33. Villaschi S, Nicosia RF. Paracrine interactions between fibroblasts and endothelial cells in a serum-free coculture model. Lab Invest, 1994;71:291-9.
34. Motro B. Itin A, Sachs L, Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 1990;87:4068-72.
35. Bussolino F, Ziehe M, Wang JM, Alessi D, Morbidelli L, Cremona O, et al. In vitro and in vivo activation of endothelial cells by colony stimulating factors. J Clin Invest 1991;87:986-95.
36. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM et al. Tansforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
37. Ribatti D, Roncali L, Nico B, Bertossi M. Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat, 1987;130:257-63.
38. Halaban R, Langdon R, Birchall W, Cuono C, Baird A, Scott G, et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988;107:1611-9.
39. Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Gonstin AS, Moses HL, Dittelkow MR. Production and autoinoculation transforming growth factor-β in human keratinocytes. Nature 1987;328:817-20.
40. Brown LF, Berse T, Yeo K, Senger DR, Dvorak HF. Van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-9.
41. Detmar M, Brown L, Claffey K, Yeo KT, Kocher O, Jackman R, et al. Overexpression of vascular permeability factor and its receptor in psoriasis. J Exp Med 1994;180:1141-6.
42. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 1995;104:744-9.
43. Le Roy EC: A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 1992;51:286.
44. Auerbach W, Auerbach R: Angiogenesis inhibition: a review. Pharm Ther 1994;63:265-311.